國際放射腫瘤學*生物學*物理學雜志(IJROBP)，在該領域被稱為紅色雜志，提供了權威的文章，將新的研究和技術與臨床應用相聯(lián)系。主要科學家和研究人員的原創(chuàng)貢獻包括聯(lián)合模式治療的實驗研究，特別是放化療方法，以及在熱療、近距離治療、高LET輻射、核醫(yī)學、放射增敏劑和放射防護劑方面的相關創(chuàng)新。還包括與腫瘤成像、劑量學和二維/三維適形放射治療規(guī)劃相關的技術進步。訪問ASTRO的網(wǎng)站http://www.astro.org，了解關于會員、教育、會議、新聞發(fā)布等方面的信息。

International Journal of Radiation Oncology*Biology*Physics (IJROBP), known in the field as the Red Journal, offers authoritative articles linking new research and technologies to clinical applications. Original contributions by leading scientists and researchers include experimental studies of combined modality treatment, especially chemoradiotherapy approaches, and relevant innovations in hyperthermia, brachytherapy, high LET irradiation, nuclear medicine, radiosensitizers, and radioprotectors. Technical advances related to tumor imaging, dosimetry, and 2-D/3-D conformal radiation treatment planning are also included. Visit the ASTRO web site at http://www.astro.org for information on membership, education, meetings, press releases and more.